Cargando…

A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Saavedra, Ana, Gómez-Cabello, Daniel, Domínguez-Sánchez, María Salud, Mejías-Navarro, Fernando, Fernández-Ávila, María Jesús, Dinant, Christoffel, Martínez-Macías, María Isabel, Bartek, Jiri, Huertas, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980490/
https://www.ncbi.nlm.nih.gov/pubmed/27503537
http://dx.doi.org/10.1038/ncomms12364
_version_ 1782447463493271552
author López-Saavedra, Ana
Gómez-Cabello, Daniel
Domínguez-Sánchez, María Salud
Mejías-Navarro, Fernando
Fernández-Ávila, María Jesús
Dinant, Christoffel
Martínez-Macías, María Isabel
Bartek, Jiri
Huertas, Pablo
author_facet López-Saavedra, Ana
Gómez-Cabello, Daniel
Domínguez-Sánchez, María Salud
Mejías-Navarro, Fernando
Fernández-Ávila, María Jesús
Dinant, Christoffel
Martínez-Macías, María Isabel
Bartek, Jiri
Huertas, Pablo
author_sort López-Saavedra, Ana
collection PubMed
description There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP.
format Online
Article
Text
id pubmed-4980490
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49804902016-08-12 A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection López-Saavedra, Ana Gómez-Cabello, Daniel Domínguez-Sánchez, María Salud Mejías-Navarro, Fernando Fernández-Ávila, María Jesús Dinant, Christoffel Martínez-Macías, María Isabel Bartek, Jiri Huertas, Pablo Nat Commun Article There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP. Nature Publishing Group 2016-08-09 /pmc/articles/PMC4980490/ /pubmed/27503537 http://dx.doi.org/10.1038/ncomms12364 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
López-Saavedra, Ana
Gómez-Cabello, Daniel
Domínguez-Sánchez, María Salud
Mejías-Navarro, Fernando
Fernández-Ávila, María Jesús
Dinant, Christoffel
Martínez-Macías, María Isabel
Bartek, Jiri
Huertas, Pablo
A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title_full A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title_fullStr A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title_full_unstemmed A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title_short A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection
title_sort genome-wide screening uncovers the role of ccar2 as an antagonist of dna end resection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980490/
https://www.ncbi.nlm.nih.gov/pubmed/27503537
http://dx.doi.org/10.1038/ncomms12364
work_keys_str_mv AT lopezsaavedraana agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT gomezcabellodaniel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT dominguezsanchezmariasalud agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT mejiasnavarrofernando agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT fernandezavilamariajesus agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT dinantchristoffel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT martinezmaciasmariaisabel agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT bartekjiri agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT huertaspablo agenomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT lopezsaavedraana genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT gomezcabellodaniel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT dominguezsanchezmariasalud genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT mejiasnavarrofernando genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT fernandezavilamariajesus genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT dinantchristoffel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT martinezmaciasmariaisabel genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT bartekjiri genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection
AT huertaspablo genomewidescreeninguncoverstheroleofccar2asanantagonistofdnaendresection